TerminatedNot Applicable

Ocular Imaging Study Using Advanced OCT

Stopped: Departmental priorities changed, partly due to COVID 19.

United States150 participantsStarted 2016-07

Plain-language summary

The purpose of this study is to evaluate this AngioScan angiography software on patients with various retinal vascular disorders. The advanced OCT instrument is an FDA approved clinically used camera, but the AngioScan angiography software is not FDA approved. Investigators would like to know if this imaging device and software can improve the quality of images and visualization of imaged tissues and whether they are useful in the diagnosis and treatment of eye diseases. Images collected in this study may be compared to other images collected as part of standard of care on the same patient (OCT, FA, AF, Fundus).

Who can participate

Age range18 Years – 115 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: • Any patient with abnormal retinal findings as determined by investigators. Exclusion Criteria: * Those suffering from head, neck or other injury which makes them unable to position themselves in head restraint for imaging. * Participants who are unable to maintain retinal fixation on a specified target. * Participants unable to achieve sufficient pupil dilation and alignment stability for imaging to take place. * Patients with media opacity which preclude high quality imaging.

What they're measuring

Retinal vascular abnormalities imaged by OCT Angiography and en face analysis of macular disorders

Timeframe: 2 years

Trial details

NCT IDNCT02827071

SponsorUniversity of California, Los Angeles

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-12-09

View on ClinicalTrials.gov More Retinal Vascular Disorder trials